Liang-Ping Xia

549 total citations
13 papers, 424 citations indexed

About

Liang-Ping Xia is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Liang-Ping Xia has authored 13 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Liang-Ping Xia's work include Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers) and Male Breast Health Studies (2 papers). Liang-Ping Xia is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers) and Male Breast Health Studies (2 papers). Liang-Ping Xia collaborates with scholars based in China, Switzerland and United States. Liang-Ping Xia's co-authors include Xiao‐Feng Zhu, Gong-Kan Feng, Min Yan, Linlin Wang, Zhong Guan, Quentin Liu, Jie Xu, Zi-Jie Long, Yan Zhao and Ting Sun and has published in prestigious journals such as Clinical Cancer Research, Molecular Cancer and Carcinogenesis.

In The Last Decade

Liang-Ping Xia

12 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liang-Ping Xia China 9 206 181 102 77 74 13 424
Craig T. Wallington‐Beddoe Australia 14 501 2.4× 143 0.8× 144 1.4× 79 1.0× 76 1.0× 32 658
Yibin Ren China 12 365 1.8× 149 0.8× 68 0.7× 163 2.1× 90 1.2× 13 531
Tony Dicker Australia 15 402 2.0× 253 1.4× 61 0.6× 54 0.7× 124 1.7× 22 633
Philip Eliades United States 9 193 0.9× 245 1.4× 88 0.9× 58 0.8× 50 0.7× 12 481
Anissa M. Jabbour Australia 13 400 1.9× 109 0.6× 43 0.4× 64 0.8× 63 0.9× 19 551
Christopher J. Nelsen United States 11 340 1.7× 211 1.2× 104 1.0× 86 1.1× 132 1.8× 11 640
Arata Shimo Japan 11 397 1.9× 154 0.9× 141 1.4× 139 1.8× 22 0.3× 17 610
Danrui Cui China 14 563 2.7× 220 1.2× 56 0.5× 92 1.2× 110 1.5× 27 655
Agnieszka Chęcińska Netherlands 9 314 1.5× 182 1.0× 65 0.6× 83 1.1× 108 1.5× 10 477

Countries citing papers authored by Liang-Ping Xia

Since Specialization
Citations

This map shows the geographic impact of Liang-Ping Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang-Ping Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang-Ping Xia more than expected).

Fields of papers citing papers by Liang-Ping Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang-Ping Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang-Ping Xia. The network helps show where Liang-Ping Xia may publish in the future.

Co-authorship network of co-authors of Liang-Ping Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Liang-Ping Xia. A scholar is included among the top collaborators of Liang-Ping Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang-Ping Xia. Liang-Ping Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wu, Rui-Yan, Pengfei Kong, Liang-Ping Xia, et al.. (2019). Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma. Clinical Cancer Research. 25(14). 4530–4541. 80 indexed citations
2.
He, Wenzhuo, Fang Wang, Lin Yang, et al.. (2019). Comparison of Mismatch Repair Status Between Primary and Matched Metastatic Sites in Patients With Colorectal Cancer. Journal of the National Comprehensive Cancer Network. 17(10). 1174–1183. 33 indexed citations
3.
Cai, Xiu-Yu, Jun Dong, Wei-Han Hu, et al.. (2016). The MMP-7-181A/G gene polymorphism is a prognostic indicator in patients with gastric cancer. Translational Cancer Research. 5(6). 748–755.
4.
Sun, Ting, Dandan Li, Linlin Wang, et al.. (2011). c-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cells. Journal of Translational Medicine. 9(1). 161–161. 68 indexed citations
5.
6.
Xia, Liang-Ping, Hui-Juan Qiu, Guifang Guo, et al.. (2010). Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 cases. Medical Oncology. 28(S1). 570–576. 3 indexed citations
7.
Xia, Liang-Ping, et al.. (2010). Analysis of prognostic factors in male breast cancer: a report of 72 cases from a single institution. Chinese Journal of Cancer. 29(3). 184–188. 9 indexed citations
8.
Xia, Liang-Ping, Peihong Wu, Jian‐Chuan Xia, et al.. (2010). One patient with metastastic colorectal cancer successfully treated by combination of targeted agents after failure of chemotherapy. Chinese Journal of Cancer. 29(12). 1023–1028. 2 indexed citations
9.
Xia, Liang-Ping, Guifang Guo, Xi Wang, et al.. (2010). Changes in therapeutic strategies in Chinese male patients with breast cancer: 40 years of experience in a single institute. The Breast. 19(6). 450–455. 20 indexed citations
10.
Guo, Guifang, et al.. (2009). Efficacy of cetuximab combined with chemotherapy on advanced colorectal cancer: a report of 53 cases. Chinese Journal of Cancer. 28(12). 1317–1323. 2 indexed citations
11.
12.
13.
Wan, Xiang‐Bo, Zi-Jie Long, Min Yan, et al.. (2008). Inhibition of Aurora-A suppresses epithelial–mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells. Carcinogenesis. 29(10). 1930–1937. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig T. Wallington‐Beddoe Breakdown of academic impact, for papers by Yibin Ren Breakdown of academic impact, for papers by Tony Dicker Breakdown of academic impact, for papers by Philip Eliades Breakdown of academic impact, for papers by Anissa M. Jabbour Breakdown of academic impact, for papers by Christopher J. Nelsen Breakdown of academic impact, for papers by Arata Shimo Breakdown of academic impact, for papers by Danrui Cui Breakdown of academic impact, for papers by Agnieszka Chęcińska
Rankless by CCL
2026